Beatrice Kallungal

Immunology and Microbiology · Life Sciences

7h-index815citations13works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(10), HIV/AIDS drug development and treatment(10), HIV/AIDS Research and Interventions(5), HIV-related health complications and treatments(3), Chemokine receptors and signaling(2)

Publications13 total

The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1–Infected Individuals
UNC Libraries·2020Open Access
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
UNC Libraries·2020Open Access
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy
UNC Libraries·2020Open Access
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
UNC Libraries·2020Open Access
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210
AIDS Research and Human Retroviruses·2019· 7 citedOpen Access
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
AIDS·2012· 42 citedOpen Access
The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1–Infected Individuals
The Journal of Infectious Diseases·2011· 104 citedOpen Access
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy
JAIDS Journal of Acquired Immune Deficiency Syndromes·2011· 107 citedOpen Access
Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
PLoS Medicine·2011· 2 citedOpen Access
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
PLoS Medicine·2010· 306 citedOpen Access
Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects
Antimicrobial Agents and Chemotherapy·2007· 2 citedOpen Access
Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects
Antimicrobial Agents and Chemotherapy·2007· 119 citedOpen Access
Clinical considerations in study designs that use cotinine as a biomarker
Biomarkers·2003· 126 cited

Frequent Co-authors

Rajesh T. Gandhi(5), Lu Zheng(5), Ronald J. Bosch(5), Ellen S. Chan(5), David M. Margolis(5), Sarah Read(5), Michael M. Lederman(5), Ann Wiegand(5), Mary F. Kearney(5), John W. Mellors(5), Joseph J. Eron(5), Karin L. Klingman(5), Kathy Medvik(3), Nadia Alatrakchi(3), John M. Coffin(3), Gary Calandra(3), Stephen Becker(3), Jeffrey M. Jacobson(3), Jeffrey M. Jacobson(2), Nimalie D. Stone(2)